Oral Mucosal Vaccination against HIV Infection (R01)

The summary for the Oral Mucosal Vaccination against HIV Infection (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Oral Mucosal Vaccination against HIV Infection (R01): -Purpose: This Funding opportunity announcement (FOA) issued by the NIDCR, National Institutes of Health, solicits applications that will focus on harnessing mucosal immune responses in order to facilitate the development of effective HIV vaccines that utilize the oropharyngeal mucosal tissues as the route of inoculation. Specifically the NIDCR is seeking applications that will further develop already characterized target vaccine antigens and formulations and relevant model antigens for oral delivery, target validation and early preclinical evaluation in relevant animal models. This FOA will not support basic vaccine antigen discovery or therapeutic vaccine research. -Mechanism of Support: This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, RFA-DE-08-004, that solicits applications under the R21award mechanism. -Funds Available and Anticipated Number of Awards: Up to $ 2 million total cost (Direct costs plus Facilities and Administrative costs) may be awarded in support of this solicitation. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Four to six new and/or competing renewal grants are anticipated.

Federal Grant Title:	Oral Mucosal Vaccination against HIV Infection (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DE-08-003
Type of Funding:	Grant
CFDA Numbers:	93.121
CFDA Descriptions:	Oral Diseases and Disorders Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Aug 15, 2007
Posted Date:	Apr 03, 2007
Creation Date:	Apr 03, 2007
Archive Date:	Sep 14, 2007
Total Program Funding:	$2,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Special district governments Public and State controlled institutions of higher education Independent school districts Private institutions of higher education Small businesses Public housing authorities/Indian housing authorities State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses County governments City or township governments
Additional Information on Eligibility: Foreign institutions are eligible to apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research ...; • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...; • NIDCR Mentoring Network to Promote a Diverse Dental, Oral and Craniofacial Research Workfo...; • Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparit...; • Epidemiological and Behavioral Research in Oral Health; • Metagenomic Analyses of the Oral Microbiome; • Phase Iii Clinical Trials in Oral Infectious Diseases
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...